Tian Ruo Pu
Director/Board Member bei ONECONNECT FINANCIAL TECHNOLOGY CO., LTD.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jing Lou | M | 61 | 31 Jahre | |
Sean Shao | M | 67 |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 16 Jahre |
Chang Yu | M | 66 | 14 Jahre | |
Tao Wu | M | - | 8 Jahre | |
Xiao Yu Li | F | 35 | 6 Jahre | |
Chongfeng Shen | M | 54 | 3 Jahre | |
Hao Han Xu | M | 29 | 5 Jahre | |
Yi Yang | F | 51 | 5 Jahre | |
Hong Gang Tian | M | 43 | 2 Jahre | |
He Yu | M | 67 | 14 Jahre | |
Han Qiu | F | 49 | 8 Jahre | |
Zhi Jun Liang | M | - | - | |
Xiao Ying Gao | M | 74 |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 13 Jahre |
Joo Yeow Ng | M | 59 | 2 Jahre | |
Jinqiu Tang | M | 41 | 5 Jahre | |
Koon Wing Ip | M | 63 | 3 Jahre | |
Quan Long | M | 54 | 3 Jahre | |
Zhang Yaolin | M | 66 | 5 Jahre | |
Siu Kuen Lai | F | 48 | 7 Jahre | |
Jun Ling Liu | M | 59 | 9 Jahre | |
Wing Kin Chow | M | 73 | 4 Jahre | |
Zhi Gang Zhao | M | 64 | 2 Jahre | |
Bin Huang | M | 63 | 31 Jahre | |
Dong Mei Su | M | 54 | 12 Jahre | |
Dazong Wang | M | 69 | 8 Jahre | |
Hoi Ti Yang | F | 54 | 3 Jahre | |
Dan Zhang | M | 60 | 2 Jahre | |
Huining Cao | M | 58 |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 14 Jahre |
Felix Chungfai Wong | M | - |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | 12 Jahre |
Fei Yang | M | - | 4 Jahre | |
Keke Ding | F | - | 1 Jahre | |
Xin Fu | F | 45 | 2 Jahre | |
Yongtao Luo | M | 49 | - | |
Chen Xuhua | M | - | 3 Jahre | |
Yuan Yuan Ren | M | - | - | |
Xingyan Gao | F | - | - | |
Xiang He | M | - | 1 Jahre | |
Dong Tao Luo | M | 48 | 8 Jahre | |
Bibo Xiang | M | 46 | 3 Jahre | |
Amit Jindal | M | - |
Accenture AG
Accenture AG Information Technology ServicesTechnology Services Accenture AG provides services and solutions in the areas of strategy, consulting, digital, technology, and operations. The company was founded on August 5, 1983 and is headquartered in Zurich, Switzerland. | 19 Jahre |
Fan Lu | M | - | 1 Jahre | |
Joseph A. Piscopo | M | - |
University of Illinois
| 29 Jahre |
Jiang Hong | F | - | - | |
Yan Zeng | M | 56 | 2 Jahre | |
Rosalie Sagraves | M | 78 |
University of Illinois
| 29 Jahre |
Wen Wei Dou | M | 58 | 7 Jahre | |
Sterling Song | M | - | - | |
Yidong Hu | M | 60 | 1 Jahre | |
Wen Jun Wang | F | 56 | 3 Jahre | |
John Sbragia | M | - | 26 Jahre | |
Xin Ma | M | 58 | - | |
Dan Xie | M | 53 | 12 Jahre | |
Dong Cheng | M | 61 | 16 Jahre | |
Jun Ma | M | 44 | 6 Jahre | |
Du Xuedong | M | 44 | 13 Jahre | |
Dai Weidong | M | 64 | 9 Jahre | |
Huang Yuxiang | M | 60 | - | |
Huang Runzhong | M | 51 | 5 Jahre | |
Suli Cui | F | 45 | 6 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Shiu Kau Wong | M | 66 | 6 Jahre | |
Lin Cong | M | 43 | 4 Jahre | |
Wangchun Ye | M | 69 | 5 Jahre | |
Zhi Ya Qian | F | 48 | 3 Jahre | |
Mao Dong Xu | M | 55 | 7 Jahre | |
Yuen Chong Wai | M | 60 | 2 Jahre | |
Liang Qi | M | 51 | 2 Jahre | |
Duan Wang | M | 54 | 1 Jahre | |
Luo Ren | M | 66 | 3 Jahre | |
Thomas Meier | M | 54 | 1 Jahre | |
Phil Case | M | - | 5 Jahre | |
Jian Liu | M | 41 | 2 Jahre | |
Christian Guilliod | M | - |
University of Illinois
| 3 Jahre |
Yan Kang | M | 52 | 1 Jahre | |
Jian Hua Shao | M | - | 2 Jahre | |
Min Lu | M | 63 | 5 Jahre | |
Jun Lang Wang | M | - | 1 Jahre | |
Li Yun Cao | F | 54 | 5 Jahre | |
Yuyang Cui | M | - | - | |
Feng Pan | M | 46 | - | |
Jun Ma | M | 61 | 5 Jahre | |
David Chao | M | 56 | 12 Jahre | |
Jian Guang Wu | M | 49 | 6 Jahre | |
Bo Tan | M | 51 | 10 Jahre | |
Himanshu Shah | M | 58 | 6 Jahre | |
Bai Chuan Du | M | 77 | 4 Jahre | |
Kevin D. Schneider | M | 62 | 6 Jahre | |
Chit Ho | M | 49 | 3 Jahre | |
Will Price | M | - |
Kellogg School of Management
| 2 Jahre |
Sean Brynjelsen | M | 52 |
University of Illinois
| 6 Jahre |
Matthew Murphy | M | - | 6 Jahre | |
David Parkinson | M | 73 | 7 Jahre | |
John P. Pascente | M | - |
University of Illinois
| 5 Jahre |
Rong Chen | F | 55 | 6 Jahre | |
Jin Jiang | F | - | 1 Jahre | |
Peter Dobie Everingham | M | 54 | 2 Jahre | |
Shane McCarthy | M | - |
Kellogg School of Management
| 3 Jahre |
Graham Goldsmith | M | 63 | 3 Jahre | |
Pu Xing | M | 56 | 3 Jahre | |
Yan Jing Jia | F | - | 5 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
China | 69 | 69,70% |
Vereinigte Staaten | 19 | 19,19% |
Cayman Islands | 15 | 15,15% |
Schweiz | 1 | 1,01% |
Vereinigtes Königreich | 0 | -.--% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Tian Ruo Pu
- Persönliches Netzwerk